Evidence map›Paper›PMID 36930723›Full record

ArticleDiabetes care2023

Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm.

Dariusz Tarasewicz, Andrew J Karter, Noel Pimentel, Howard H Moffet, Khanh K Thai, David Schlessinger, Oleg Sofrygin, Ronald B Melles

Abstract read
In one paragraph

Article in Diabetes care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dariusz Tarasewicz1Department of Ophthalmology, The Permanente Medical Group, Oakland, CA.ORCID 0000-0002-5573-3792
Andrew J Karter2Division of Research, Kaiser Permanente, Oakland, CA.ORCID 0000-0001-5527-316X
Noel Pimentel2Division of Research, Kaiser Permanente, Oakland, CA.
Howard H Moffet2Division of Research, Kaiser Permanente, Oakland, CA.
Khanh K Thai2Division of Research, Kaiser Permanente, Oakland, CA.
David Schlessinger2Division of Research, Kaiser Permanente, Oakland, CA.
Oleg Sofrygin2Division of Research, Kaiser Permanente, Oakland, CA.
Ronald B Melles1Department of Ophthalmology, The Permanente Medical Group, Oakland, CA.ORCID 0000-0003-1027-4083

Funding

Translational Research Core - Health Engagement & Action Translational (HEAT)P30DK092924 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI Alyce Sophia Adams, HILARY Kessler SELIGMAN · 2011 to 2026
$9.2M
Optimizing Medical Decision Making for Older Patients with Type 2 DiabetesR01AG063391 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI HUANG, ELBERT S., KARTER, ANDREW JOHN · 2019 to 2023
$3.2M
NIA NIH HHS R01 AG063391NIDDK NIH HHS P30 DK092924
6 · The paper itself

Abstract

objectiveAlthough diabetic retinopathy is a leading cause of blindness worldwide, diabetes-related blindness can be prevented through effective screening, detection, and treatment of disease. The study goal was to develop risk stratification algorithms for the onset of retinal complications of diabetes, including proliferative diabetic retinopathy, referable retinopathy, and macular edema. RESEARCH DESIGN AND

methodsRetrospective cohort analysis of patients from the Kaiser Permanente Northern California Diabetes Registry who had no evidence of diabetic retinopathy at a baseline diabetic retinopathy screening during 2008-2020 was performed. Machine learning and logistic regression prediction models for onset of proliferative diabetic retinopathy, diabetic macular edema, and referable retinopathy detected through routine screening were trained and internally validated. Model performance was assessed using area under the curve (AUC) metrics.

resultsThe study cohort (N = 276,794) was 51.9% male and 42.1% White. Mean (±SD) age at baseline was 60.0 (±13.1) years. A machine learning XGBoost algorithm was effective in identifying patients who developed proliferative diabetic retinopathy (AUC 0.86; 95% CI, 0.86-0.87), diabetic macular edema (AUC 0.76; 95% CI, 0.75-0.77), and referable retinopathy (AUC 0.78; 95% CI, 0.78-0.79). Similar results were found using a simpler nine-covariate logistic regression model: proliferative diabetic retinopathy (AUC 0.82; 95% CI, 0.80-0.83), diabetic macular edema (AUC 0.73; 95% CI, 0.72-0.74), and referable retinopathy (AUC 0.75; 95% CI, 0.75-0.76).

conclusionsRelatively simple logistic regression models using nine readily available clinical variables can be used to rank order patients for onset of diabetic eye disease and thereby more efficiently prioritize and target screening for at risk patients.

Indexed as

Diabetes MellitusDiabetic RetinopathyMacular EdemaAgedAlgorithmsBlindnessFemaleHumansMaleMiddle AgedRetrospective StudiesRisk Assessment

Identifiers

PMID36930723
PMCPMC10257789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.